SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001136261-18-000096
Filing Date
2018-04-09
Accepted
2018-04-09 16:18:49
Documents
7
Period of Report
2018-05-22
Effectiveness Date
2018-04-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a.htm DEF 14A 526831
2 SIGNATURE image3505.jpg GRAPHIC 82952
3 SIGNATURE smallken.jpg GRAPHIC 41834
4 CARD image002.jpg GRAPHIC 109397
5 CARD image004.jpg GRAPHIC 78053
6 CARD image010.jpg GRAPHIC 69069
7 CARD image012.jpg GRAPHIC 65848
  Complete submission text file 0001136261-18-000096.txt   1144486
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

IRS No.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14494 | Film No.: 18745765
SIC: 2834 Pharmaceutical Preparations